JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 29, 2005; DOI: 10.1124/jpet.105.084236


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084236v1
314/1/61    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reese, B. E
Right arrow Articles by Yun, J. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reese, B. E
Right arrow Articles by Yun, J. K
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH


Received for publication January 28, 2005.
Revised March 25, 2005.
Accepted for publication March 25, 2005.

Protein Kinase C{epsilon} Regulates TNF{alpha}-Induced Stannin Gene Expression

Brian E Reese 1, Collin E Davidson 2, Melvin L Billingsley 1*, Jong K Yun 1

1 Pennsylvania State University 2 Pennsylvania State Univiersity

* Address correspondence to: E-mail: mlb8{at}psu.edu

Abstract

Stannin (Snn) is a highly conserved vertebrate protein that has been closely linked to trimethyltin (TMT) toxicity. We have previously demonstrated that Snn is required for TMT-induced cell death. Others have shown that TMT exposure results in TNF{alpha} production, and that TNF{alpha} treatment induces Snn gene expression in human umbilical vein endothelial cells (HUVECs). In this study, we investigated a signaling mechanism by which Snn gene expression is regulated by TMT, and demonstrate that TNF{alpha} stimulates Snn gene expression in a protein kinase C{epsilon}-dependent manner in HUVECs in response to TMT exposure. Supporting this, we show that TMT-induced toxicity is significantly blocked by pretreatment with an anti-TNF{alpha} antibody in HUVECs. Using a quantitative real- time polymerase chain reaction assay, we also show that the level of Snn gene expression is significantly increased in HUVECs in response to either TMT or TNF{alpha} treatment. This TNF{alpha}-induced Snn gene expression is blocked when HUVECs were pretreated with bisindolylmaleimide I, an inhibitor of protein kinase C (PKC). In contrast, when HUVECs were treated with phorbol 12-myristate, 13-acetate, a PKC activator, we observed a significant increase in Snn gene expression. Using isotype-specific siRNA against PKC, we further show that knockdown of PKC{epsilon}, but not PKC-{delta} or -{zeta} significantly blocked TNF{alpha}- induced Snn gene expression. Together, these results indicate that TNF{alpha}-induced, PKC{epsilon}- dependent Snn expression may be a critical factor in TMT- induced cytotoxicity.


Key words: PKC, Selective toxicity, Stannin, TNF, Trimethyltin, organotin





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.